Cytoseek
Hone Bio (formerly Cytoseek) develops NanoPilot technology to engineer lipid nanoparticles for targeted extrahepatic drug delivery. The platform enables therapeutics like mRNA to reach specific cell types while actively blocking off-target uptake in the liver. The company provides these delivery solutions for the biotech and pharmaceutical industries through licensing and pre-clinical development.
Biotech
Drug Delivery
Healthtech
Funding summary
- Total raised
- €5.3M
- Funding rounds
- 2
Investors in Cytoseek
Investors on record for Cytoseek. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Cytoseek?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors